Analysts Have Made A Financial Statement On Nihon Kohden Corporation's (TSE:6849) Full-Year Report

Investors in Nihon Kohden Corporation (TSE:6849) had a good week, as its shares rose 4.9% to close at JP¥1,804 following the release of its annual results. It was a credible result overall, with revenues of JP¥225b and statutory earnings per share of JP¥84.88 both in line with analyst estimates, showing that Nihon Kohden is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus from Nihon Kohden's eight analysts is for revenues of JP¥238.6b in 2026. This would reflect an okay 5.8% increase on its revenue over the past 12 months. Per-share earnings are expected to climb 13% to JP¥97.42. Yet prior to the latest earnings, the analysts had been anticipated revenues of JP¥236.0b and earnings per share (EPS) of JP¥98.35 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

See our latest analysis for Nihon Kohden

The analysts reconfirmed their price target of JP¥2,353, showing that the business is executing well and in line with expectations. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. There are some variant perceptions on Nihon Kohden, with the most bullish analyst valuing it at JP¥3,300 and the most bearish at JP¥1,500 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Nihon Kohden's past performance and to peers in the same industry. It's clear from the latest estimates that Nihon Kohden's rate of growth is expected to accelerate meaningfully, with the forecast 5.8% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 3.6% p.a. over the past five years. Other similar companies in the industry (with analyst coverage) are also forecast to grow their revenue at 6.0% per year. Nihon Kohden is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Nihon Kohden analysts - going out to 2028, and you can see them free on our platform here.

We also provide an overview of the Nihon Kohden Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.